Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA | Zendy

Nora S. Sánchez | Zendy; Michael Kahle | Zendy; Ann M. Bailey | Zendy; Chetna Wathoo | Zendy; Kavitha Balaji | Zendy; Mehmet Demirhan | Zendy; Dong Yang | Zendy; Milind Javle | Zendy; Ahmed O. Kaseb | Zendy; Cathy Eng | Zendy; Vivek Subbiah | Zendy; Filip Janků | Zendy; Victoria M. Raymond | Zendy; Richard B. Lanman | Zendy; Kenna Shaw | Zendy; Funda MericBernstam | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA

Author(s) -

Nora S. Sánchez,

Michael Kahle,

Ann M. Bailey,

Chetna Wathoo,

Kavitha Balaji,

Mehmet Demirhan,

Dong Yang,

Milind Javle,

Ahmed O. Kaseb,

Cathy Eng,

Vivek Subbiah,

Filip Janků,

Victoria M. Raymond,

Richard B. Lanman,

Kenna Shaw,

Funda MericBernstam

Publication year - 2019

Publication title -

jco precision oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.405

H-Index - 22

ISSN - 2473-4284

DOI - 10.1200/po.19.00017

Subject(s) - identification (biology) , computational biology , genomic dna , dna , cell free fetal dna , biology , genetics , ecology , pregnancy , fetus , prenatal diagnosis

Cell-free DNA (cfDNA) next-generation sequencing is a noninvasive approach for genomic testing. We report the frequency of identifying alterations and their clinical actionability in patients with advanced/metastatic cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research